Several previous studies consistently showed that adropin played a critical role in maintaining glucose homeostasis, increasing the glucose utilization, improving glucose tolerance, and reducing insulin resistance (Butler et al., 2019; Jasaszwili et al., 2020). Here, ENHO is linked to Insulin resistance.